Multicenter Phase II Clinical Trial of Sorafenib Combined with TACE for Advanced Stage HCC (STAB Study)

PURPOSE To evaluate the safety and efficacy of combination therapy (TACE+ sorafenib) in patients with advanced stage HCC. STUDY DESIGN Open-label, non-randomized, single-arm multicenter phase II clinical trial. The primary endpoint was defined as the rate of completion of the treatment protocol (i.e., 2 months duration of sorafenib following TACE); Read more…

Military Match and IR

Written by: Chris Choe, University of Tennessee College of Medicine MS3 Rose Miller, The Ohio State University College of Medicine, MS3   General Overview about Military Match While currently a rare topic of discussion, IR opportunities in the military are increasing. Medical students choose a career in military medicine for various reasons. For many Read more…